Csaba G, Dobozy O, Inczefi-Gonda A, Szeberényi S
Department of Biology, Semmelweis University Medical School, Budapest, Hungary.
Acta Physiol Hung. 1988;71(3):421-7.
Healthy and neonatally castrated male rats were treated with testosterone twice perinatally, while other groups were treated with testosterone also in adulthood or received testosterone only in adulthood. Castration resulted in a moderate (but in some instances significant) decrease of PSMO (polysubstrate monooxygenase) level measured in adulthood. The decrease could partially be compensated by perinatal testosterone treatment. Further testosterone treatment administered in adulthood did not result in further alteration when compared either with the controls or with the neonatally treated animals. However, since in the controls the second testosterone treatment (following the neonatal one), had a decreasing effect, therefore the testosterone treatment administered in adulthood was responsible for the disappearance of the difference between the castrated animals and the controls treated both perinatally and in adulthood. On the basis of these findings it seems likely that the perinatal presence of testosterone plays a major role in the development of enzymatic imprinting and thus, in securing the capability of the liver to split testosterone in adulthood. Since testosterone influences the glycocorticoid receptors of the thymus (presumably by its overlapping effect), so the amount of free glycocorticoid receptors is always higher in the animals castrated neonatally than in the controls. Conversely, neonatal testosterone treatment somewhat increases the number of receptors detectable in adulthood.
健康的和新生期阉割的雄性大鼠在围产期接受两次睾酮治疗,而其他组在成年期也接受睾酮治疗或仅在成年期接受睾酮治疗。阉割导致成年期测量的PSMO(多底物单加氧酶)水平适度(但在某些情况下显著)下降。围产期睾酮治疗可部分补偿这种下降。与对照组或新生期接受治疗的动物相比,成年期进一步给予睾酮治疗并未导致进一步改变。然而,由于在对照组中,第二次睾酮治疗(在新生期治疗之后)具有降低作用,因此成年期给予的睾酮治疗导致了阉割动物与围产期和成年期均接受治疗的对照组之间差异的消失。基于这些发现,围产期睾酮的存在似乎在酶印记的发展中起主要作用,从而确保肝脏在成年期分解睾酮的能力。由于睾酮影响胸腺的糖皮质激素受体(可能通过其重叠作用),因此新生期阉割的动物中游离糖皮质激素受体的数量总是高于对照组。相反,新生期睾酮治疗在一定程度上增加了成年期可检测到的受体数量。